News file for: Prostate Cancer
Researchers and clinicians in Australia are leading a clinical trial to test a GPS-like device that tracks the position of the prostate as it moves during radiotherapy.
Medifocus has entered into a joint venture agreement with Ideal Concept Group to sell and market its Prolieve treatment in China and other Asian countries.
BioChain and Epigenomics AG have announced a collaboration to bring Epigenomics’ Septin9 colorectal cancer screening technology to China.
Scientists have completed the first ever analysis of national trends in cancer incidence among the eight largest Asian American groups.
The Prostate Cancer Foundation has funded two new young Chinese investigators to lead innovative prostate cancer research projects within the country.
Two common viruses known to be associated with human cancers are both present in most prostate cancers, a new study suggests.
Innovative new technology has been used to identify and profile a novel combination of proteins that may improve treatment for prostate disorders.
The Prostate Cancer Foundation announced yesterday the launch of PCF China, a research initiative that will identify, fund, and promote innovative research projects within China.
Takeda has initiated enrollment of patients in Japan for the two ongoing global Phase III clinical trials for its anti-prostate cancer investigational agent, orteronel (TAK-700).
Researchers at the Centenary Institute in Sydney have found that prostate cancer cells have more pumps for the essential nutrient leucine, revealing a potential target for treatment through starving these tumor cells.